Using a Quantitative High-Throughput Screening Platform to Identify Molecular Targets and Compounds as Repurposing Candidates for Endometriosis.

Biomolecules · 2023 · PMC10296532 · PMID 37371546

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

This study also demonstrates novel pathways and new molecular targets that may be significant contributors to endometriosis pathogenesis, inflammation, and nociception pain pathways and provides several new avenues of investigation for future endometriosis pathophysiological studies.

also in 5,131 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.